Kennedy Kelly J.
SEC Form 4 insider trading activity
Kennedy Kelly J. has filed 6 SEC Form 4 filings (6 transaction rows) across 3 companies, including GDRX, VITL, SATL, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jun 18, 2026.
On the most recent filing, Kennedy Kelly J. is listed as Director at Vital Farms, Inc. Inside the rolling window, Kennedy Kelly J. reported 1 open-market purchase totaling $21K in VITL and no open-market sales.
Companies traded
Other insiders at GDRX
Insider Buying
$21K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kennedy Kelly J. made?
Kennedy Kelly J. has filed 6 SEC Form 4 filings (6 transaction rows) across 3 companies, including GDRX, VITL, SATL since 2025.
Which companies does Kennedy Kelly J. trade?
Kennedy Kelly J. has filed SEC Form 4 disclosures for 3 companies, including GDRX, VITL, SATL.
When was Kennedy Kelly J.'s most recent SEC Form 4 filing?
Kennedy Kelly J.'s most recent SEC Form 4 filing on Tracefour is dated Jun 18, 2026.
What is Kennedy Kelly J.'s total buy and sell value in the current window?
Inside the rolling retention window, Kennedy Kelly J. bought $21K and sold $0 based on SEC Form 4 filings.
What was Kennedy Kelly J.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,500 VITL shares on 2026-05-14, worth $21K, per SEC Form 4 filings.